1. The contribution of Gianni Bonadonna to the history of chemotherapy

   • Domenico Ribatti

   Review 11 January 2007 Pages: 309 - 312

2. Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIP_L

   • Tamer E. Fandy
   • Douglas D. Ross
   • Rakesh K. Srivastava

   Original Article 23 December 2006 Pages: 313 - 319

   

3. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer

   • Yong Sang Hong
   • Jeeyun Lee
   • Won Ki Kang

   Original Article 02 December 2006 Pages: 321 - 328

   

4. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs

   • Henk M. W. Verheul
   • David Z. Qian
   • Roberto Pili

   Original Article 26 January 2007 Pages: 329 - 339

   

5. Efficacy of SSG and SSG/IFNα2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action

   • Jing Li
   • Daniel J. Lindner
   • Taolin Yi

   Original Article 14 November 2006 Pages: 341 - 349

   

6. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer

   • Peng-Chan Lin
   • Wei-Shone Chen
   • Jin-Hwang Liu

   Original Article 17 November 2006 Pages: 351 - 356

   

7. Sunitinib malate

   • Hassane Izzedine
   • Irina Buhaescu
   • Gilbert Deray

   Original Article 30 November 2006 Pages: 357 - 364

8. Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study

   • J. Bonneterre
   • M. Campone
   • I. Douville

   Original Article 25 November 2006 Pages: 365 - 373

9. Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study

   • E. G. C. Brain
   • K. Rezai
   • F. Lokiec

   Original Article 15 November 2006 Pages: 375 - 381

   

10. Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer

    • Jacqueline Duffour
    • Sophie Gourgou
    • Marc Ychou

    Original Article 24 November 2006 Pages: 383 - 389

11. A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers

    • D. Ross Camidge
    • Dominic Smethurst
    • Andrew Hughes

    Original Article 18 November 2006 Pages: 391 - 398

    

12. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

    • Hideaki Katori
    • Mamoru Tsukuda
    • Kiichi Watai

    Original Article 10 November 2006 Pages: 399 - 406

    

13. Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours

    • H. Bourgeois
    • J. Vermorken
    • C. Puozzo

    Original Article 31 May 2007 Pages: 407 - 413

    

14. O⁶-benzylguanine and BCNU in multiple myeloma: a phase II trial

    • Eric D. Batts
    • Christopher Maisel
    • Stanton L. Gerson

    Original Article 13 March 2007 Pages: 415 - 421

15. Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB

    • Vincent A. Pollack
    • Enrique Alvarez
    • William J. LaRochelle

    Original Article 01 June 2007 Pages: 423 - 435

    

16. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer

    • Elham Fakhrejahani
    • Akiko Miyamoto
    • Nobuhiko Tanigawa

    Original Article 22 March 2007 Pages: 437 - 446

    

17. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer

    • Elham Fakhrejahani
    • Akiko Miyamoto
    • Nobuhiko Tanigawa

    Erratum 08 May 2007 Pages: 447 - 447

    

18. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells

    • Hiromi Sato
    • Keiko Fukumoto
    • Tomohiro Yano

    Short Communication 16 February 2007 Pages: 449 - 457

    

19. A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge

    • Gabriella Ferrandina
    • Francesco Legge
    • Giovanni Scambia

    Short Communication 11 April 2007 Pages: 459 - 461

20. Announcement

    Announcement 14 June 2007 Pages: 463 - 465